ZYDUS LIFESCIENCES LTD.
Market Cap.(`)
|
112280.62 Cr.
|
P/BV
|
5.66
|
Book Value (`)
|
197.07
|
52 Week High/Low ( ` )
|
1324/568
|
FV/ML
|
1/1
|
P/E(X)
|
29.09
|
Book Closure
|
26/07/2024
|
EPS (`)
|
38.36
|
Div Yield (%)
|
0.27
|
(` in Crs.)
You can view the
Consolidated
Income Statement
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 19021.50 | 16877.80 | 14827.60 | 14125.00 | 13812.10 |
Other Operating Revenues | 525.90 | 359.60 | 437.60 | 278.50 | 441.00 |
Total Operating Revenues | 19547.40 | 17237.40 | 15265.20 | 14403.50 | 14253.10 |
| | | | | |
Other Income | 284.10 | 186.60 | 224.70 | 45.60 | 113.90 |
Total Revenue | 19831.50 | 17424.00 | 15489.90 | 14449.10 | 14367.00 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 4580.50 | 4122.60 | 4042.90 | 3669.00 | 3459.60 |
Purchase Of Stock-In Trade | 1897.90 | 1949.40 | 1864.60 | 1289.30 | 1554.20 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -250.20 | 238.10 | -362.30 | -156.20 | -93.80 |
Employee Benefit Expenses | 3137.60 | 2765.60 | 2434.10 | 2295.10 | 2395.80 |
Finance Costs | 81.20 | 129.90 | 127.00 | 158.80 | 341.80 |
Depreciation And Amortisation Expenses | 764.10 | 722.70 | 713.00 | 669.60 | 696.50 |
Other Expenses | 4797.30 | 4301.80 | 3945.20 | 3919.20 | 4153.90 |
Total Expenses | 15008.40 | 14230.10 | 12764.50 | 11844.80 | 12508.00 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 4823.10 | 3193.90 | 2725.40 | 2604.30 | 1859.00 |
| | | | | |
Exceptional Items | -14.20 | -604.20 | 112.70 | -205.10 | -363.60 |
Profit/Loss Before Tax | 4808.90 | 2589.70 | 2838.10 | 2399.20 | 1495.40 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 1492.60 | 690.40 | 441.50 | 453.00 | 237.70 |
Deferred Tax | -515.10 | -102.60 | 70.20 | -259.40 | 82.10 |
Total Tax Expenses | 977.50 | 587.80 | 511.70 | 193.60 | 319.80 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 3831.40 | 2001.90 | 2326.40 | 2205.60 | 1175.60 |
| | | | | |
Profit/Loss From Continuing Operations | 3831.40 | 2001.90 | 2326.40 | 2205.60 | 1175.60 |
| | | | | |
Profit/Loss From Discontinuing Operations | 29.20 | -7.00 | 2394.20 | -114.40 | 0.00 |
Total Tax Expenses Discontinuing Operations | 6.20 | -2.40 | 148.50 | -46.40 | 0.00 |
Net Profit/Loss From Discontinuing Operations | 23.00 | -4.60 | 2245.70 | -68.00 | 0.00 |
Profit/Loss For The Period | 3854.40 | 1997.30 | 4572.10 | 2137.60 | 1175.60 |
| | | | | |
Minority Interest | -113.30 | -131.60 | -131.00 | -51.40 | -27.80 |
Share Of Profit/Loss Of Associates | 118.40 | 94.60 | 46.20 | 47.40 | 28.80 |
Consolidated Profit/Loss After MI And Associates | 3859.50 | 1960.30 | 4487.30 | 2133.60 | 1176.60 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 38.14 | 19.30 | 43.83 | 20.84 | 11.49 |
Diluted EPS (Rs.) | 38.14 | 19.30 | 43.83 | 20.84 | 11.49 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 620.80 | 266.50 | 372.00 | 0.00 | 716.60 |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 140.30 |